NCT07721545 — Perforating Artery Infarction trial site landscape

Public-registry site landscape for NCT07721545, a Perforating Artery Infarction study sponsored by Neurodawn Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07721545 (registry record)
Sponsor	Neurodawn Pharmaceutical Co., Ltd.
Condition(s)	Perforating Artery Infarction; PAI
Phase	PHASE2 / PHASE3
Listed sites	1
Site countries	China

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07721545 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.